Nature Reviews Drug Discovery 9, 348–349 (2010)
The news in brief article noted that there were six new investigational drugs in clinical trials for tuberculosis. However, in addition to the six compounds mentioned, three other compounds are in clinical trials for tuberculosis: moxifloxacin (TB Alliance/Bayer) and gatifloxacin (OFLOTUB Consortium/TDR) are in Phase III development; and PNU-100480 (Pfizer) is in Phase I development.
Additional information
The online version of the original article can be found at 10.1038/nrd3176
Rights and permissions
About this article
Cite this article
Erratum: Coalition to reduce development time of TB drug combinations. Nat Rev Drug Discov 9, 660 (2010). https://doi.org/10.1038/nrd3250
Issue date:
DOI: https://doi.org/10.1038/nrd3250
